Clinical Trials in Los Angeles

Showing 1661-1680 of 8,055 trials

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

NCT04853017

This is a Phase 1 study to assess the safety and efficacy of ELI-002 immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph-CpG-7909\] plus a mixture of lipid-conjugated peptide-based antigens \[Amph-Peptides\]) as adjuvant treatment of minimal residual disease (MRD) in subjects with KRAS/neuroblastoma ras viral oncogene homolog (NRAS) mutated PDAC or other solid tumors.

Minimal Residual DiseaseKRAS G12DKRAS G12R+9 more

Elicio Therapeutics25 participantsStarted Oct 2021

Duarte, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +7 more locations

COMPLETEDNA< 1 mile

Adolescent Acts of Kindness Intervention With Reflection

NCT05267132

Adolescents will complete a 4-week intervention, during which they will either complete a kind act for others, complete a kind act for others with a reflection component, or report their daily activities three days per week. Psychological measures will be indexed before and after the intervention.

Mental Health Wellness 1

University of California, Los Angeles119 participantsStarted Aug 2023

Los Angeles, California, United States

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Adolescent Acts of Kindness Intervention With Reflection

Find Trials by Condition in Los Angeles

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

CREST-2 Long-term Observational Extension Study

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Skin Reactions Related to Thoracic Implantable Chamber Dressings